| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 61.3531 | 65 |
| GSM780708 | Untreated after 4 days (C2_1) | 61.9615 | 66 |
| GSM780709 | Untreated after 4 days (C3_1) | 58.9033 | 64 |
| GSM780719 | Untreated after 4 days (C1_2) | 55.7636 | 60 |
| GSM780720 | Untreated after 4 days (C2_2) | 57.6146 | 62 |
| GSM780721 | Untreated after 4 days (C3_2) | 48.4472 | 43 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 62.0952 | 66 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 58.0807 | 63 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 71.0102 | 69 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 62.7941 | 66 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 61.7732 | 66 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 66.9826 | 68 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 55.2136 | 60 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 53.5453 | 57 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 61.5762 | 65 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 52.9468 | 56 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 58.6941 | 63 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 64.312 | 67 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 58.7472 | 63 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 65.7266 | 67 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 62.0952 | 66 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 55.2725 | 60 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 68.0239 | 68 |